President Donald Trump is targeting prescription drug costs. He signed a wide-ranging Trump drug price executive order. This order directs the Department of Health and Human Services (HHS). HHS will pursue changes to Medicare’s drug price negotiations. This move signals a potential shift favoured by drugmakers. The pharmaceutical industry has lobbied against negotiation timelines. Currently, complex biologics are negotiated after…
Tag: prescription drugs
-
GLP-1 drugs increase healthcare costs for obese patients
GLP-1 drugs, such as Novo Nordisk’s Wegovy, have become popular for weight loss among US patients struggling with obesity. Despite significant weight-loss benefits, an analysis of US health insurance claims reveals that these medications may drive healthcare costs higher rather than reducing obesity-related expenses. According to data from Prime Therapeutics, a pharmacy benefits manager, US patients’ average annual medical expenses…